• Business Development
  • Strategic Alliances

Business Development

TheraCarb’s business model revolves around risk management and sustainability. We believe in product development through partnerships, and have partnered our lead program with BioVeris Corp., which recently spun-off its vaccine division to operate independently as Wellstat Vaccines.

Scientific diligence:

As science is never a certainty, TheraCarb aims to broaden its technology and product pipeline to maximize commercial potential.

Careful execution:

A carefully executed step-wise approach helps afford TheraCarb the resource flexibility necessary for product development.

Proper management:

At all levels, TheraCarb will seek the right people at the right time to cultivate value growth.